Rising drug prices have been thrust into the limelight by the US presidential nomination campaigns. We look at the implications for the healthcare industry in light of this increased scrutiny.
This quarter's Sustainable Investment Report focuses on the lessons we can learn from the UK's vote to Brexit, which revealed deeper issues that stretch beyond the UK's membership of the EU.
Schroders’ ESG team examines the social pressures that led the UK to vote Leave and the challenges and opportunities they imply for global industries and markets.
As focus on climate change intensifies, portfolio carbon footprints can be a helpful tool for investors but may not provide a complete picture of future risks and opportunities